With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.80945-83-1,2-Chlorobenzothiazole-6-carbonitrile,as a common compound, the synthetic route is as follows.
Step B:; A solution of 2-chlorobenzothiazole-6-carbonitrile (14.9 g, 0.077 mol) in DMF (250 ml.) was added drop-wise at 100C to a mixture of anhydrous piperazine (60 g, 0.698 mol) and DMF (30OmL). Then the mixture was stirred for 2 h. Water (1 ,550 ml.) was added and the mixture was extracted with dichloromethane (5 x 500 ml_). The combined organic extracts was washed with water (6 x 500 ml_), dried (Na2SO4), filtered and evaporated to give a residue which was re-crystallised from ethyl acetate. This afforded 10.5 g (56 percent) of 2-(piperazin-1- yl)benzothiazole-6-carbonitrile. A mixture of this piperazine derivative (19.4 g, O.Odeltamol), sodium iodide (1.94 g), triethylamine (9.6 g, 0.095mol) and DMF (8OmL) was heated with stir-
As the paragraph descriping shows that 80945-83-1 is playing an increasingly important role.
Reference£º
Patent; NOVO NORDISK A/S; WO2007/110364; (2007); A1;,
Thiazole | C3H3NS – PubChem
Thiazole | chemical compound | Britannica